MY136733A - Carbamate compounds for use in preventing or treating psychotic disorders - Google Patents
Carbamate compounds for use in preventing or treating psychotic disordersInfo
- Publication number
- MY136733A MY136733A MYPI20020737A MY136733A MY 136733 A MY136733 A MY 136733A MY PI20020737 A MYPI20020737 A MY PI20020737A MY 136733 A MY136733 A MY 136733A
- Authority
- MY
- Malaysia
- Prior art keywords
- formula
- group
- preventing
- psychotic disorders
- phenyl
- Prior art date
Links
- 208000028017 Psychotic disease Diseases 0.000 title abstract 2
- 150000004657 carbamic acid derivatives Chemical class 0.000 title 1
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical class [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 abstract 3
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical compound BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 abstract 2
- 150000002367 halogens Chemical group 0.000 abstract 2
- -1 AMINO Chemical class 0.000 abstract 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 abstract 1
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical class N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 abstract 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical class [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N Nitrogen dioxide Chemical class O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 abstract 1
- 229910052794 bromium Inorganic materials 0.000 abstract 1
- 229910052801 chlorine Inorganic materials 0.000 abstract 1
- 239000000460 chlorine Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229910052731 fluorine Inorganic materials 0.000 abstract 1
- 239000011737 fluorine Substances 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 229910052740 iodine Inorganic materials 0.000 abstract 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 abstract 1
- 239000011630 iodine Substances 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
THIS INVENTION IS DIRECTED TO AMETHOD FOR PREVENTING OR TREATING PSYCHOTIC DISORDERS COMPRISING ADMINISTERING TOA SUBJECT IN NEED THEREOF A THERAPEUTICALLY EFFECTIVE AMOUNT OF A COMPOUND SELECTED FROM THE GROUP CONSISTING OF FORMULA (I) AND FORMULA (II): FORMULA (I) FORMULA (II)WHEREIN PHENYL IS SUBSTITUTED AT X WITH ONE TO FIVE HALOGEN ATOMS SELECTED FROM THE GROUP CONSISTING OF FLUORINE, CHLORINE , BROMINE AND IODINE; AND, R1, R2, R3, R4,R5, AND R6 ARE INDEPENDENTLY SELECTED FROM THE GROUP CONSISTING OF HYDROGEN AND C1-C4 ALKYL ; WHEREIN C1-C4 ALKYL IS OPTIONALLY SUBSTITUTED WITH PHENYL (WHEREIN PHENYL IS OPTIONALLY SUBSTITUTED WITH SUBSTITUENTS INDEPENDENTLY SELECTED FROM THE GROUP CONSISTING OF HALOGEN , C1-C4 ALKYL, C1-C4 ALKOXY, AMINO, NITRO AND CYANO).
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/081,761 US6541513B2 (en) | 2001-02-27 | 2002-02-21 | Carbamate compounds for use in preventing or treating psychotic disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY136733A true MY136733A (en) | 2008-11-28 |
Family
ID=45893881
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI20020737 MY136733A (en) | 2002-02-21 | 2002-03-01 | Carbamate compounds for use in preventing or treating psychotic disorders |
Country Status (1)
| Country | Link |
|---|---|
| MY (1) | MY136733A (en) |
-
2002
- 2002-03-01 MY MYPI20020737 patent/MY136733A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20071921L (en) | Methods for treating epileptogenesis and epilepsy | |
| YU67703A (en) | Carbamate compounds for use in preventing or treating movement disorders | |
| MY138156A (en) | Carbamate compounds for use in preventing or treating neurodegenerative disorders | |
| IL189003A0 (en) | Methods for treating substance-related disorders | |
| WO2007008562A3 (en) | Carbamate compounds for use in treating neurodegenerative disorders | |
| IL157590A0 (en) | Carbamate compounds for use in preventing or treating bipolar disorder | |
| MY133370A (en) | Carbamate compounds for use in preventing or treating bipolar disorders | |
| IL157594A0 (en) | Carbamate compounds for use in preventing or treating anxiety disorders | |
| MY129312A (en) | Carbamate compounds for use in the treatment of pain | |
| TW200744575A (en) | Methods of treating epileptogenesis | |
| MX2009004553A (en) | Methods for treatment of cochlear and vestibular disorders. | |
| IL159847A0 (en) | Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain | |
| MY136733A (en) | Carbamate compounds for use in preventing or treating psychotic disorders | |
| MY136347A (en) | Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain | |
| TW200701978A (en) | Methods of treating epileptogenesis and epilepsy |